|
|
||||||||
J Thorac Cardiovasc Surg 2003;125:217-218
© 2003 The American Association for Thoracic Surgery
Brief Communications |
From the Division of Adult Cardiac Surgery, University Hospital La Timone, Marseille, France.
Received for publication May 28, 2002. Accepted for publication June 13, 2002. Address for reprints: T. Mesana, MD, PhD, Chief, Division of Cardiac Surgery, University of Ottawa Heart Institute, 40, Ruskin Street, Ottawa, Ontario, Canada (E-mail: tmesana{at}ottawaheart.ca).
|
Clinical summary
Between May 1987 and October 2001, a total of 20 cases of Q fever endocarditis were diagnosed in our unit in 16 male and 4 female patients aged 36 to 79 years. Fever was reported in 13 patients and was discovered retrospectively. A peripheral embolic event revealed the diagnosis in 2 patients. As regards predisposition of the valve for endocarditis, we observed similar previous damage on aortic (9/20 [45%]) versus mitral (11/20 [55%]) valves and a similar ratio between native valves (9 patients) and prostheses (11 patients). Echocardiography mostly showed paraprosthetic leak or bioprosthetic deterioration with few signs of endocarditis, highlighting cardiac vegetation in only 4 patients and minimal abscess in 2 patients. Blood culture results remained negative in every patient. The diagnosis was assessed preoperatively in only 9 patients, suspected intraoperatively in 3 patients, and discovered postoperatively after routine bacterial analysis of valve specimens in 4 patients. In all instances, Coxiella burnetii was identified by means of indirect microimmunofluorescence on blood sampling, detecting antibodies directed against phase I and phase II antigens, with a serologic threshold of 1:800 immunoglobulin G (IgG) and 1:50 IgA. Our series showed 4 other patients having strictly normal functioning prostheses, which were successfully treated only with medication. We performed 8 mitral valve procedures (including 2 repairs), 7 aortic valve replacements (including 4 root replacements [3 homografts]), and a double valve replacement. All patients received prolonged oral specific antibiotics (doxycycline and hydroxychloroquine) for at least 18 months under serologic guidance.
1,5 We observed no operative mortality, no relapses, and 2 noncardiac late deaths (2/20 [10%]).
Comment
Coxiella burnetii endocarditis is considered rare, although it represents 3% to 5% endocarditis.
1,4 In our hospital, where the Referral Center for Rickettsioses is situated, active Q fever was the most frequent cause in the presence of negative blood culture endocarditis, and the frequency increased with time and more aggressive search. We first performed serologic tests between 1987 and 1993 in the presence of clinical evidence of endocarditis, despite negative blood culture results, and then in the event of any unexplained inflammatory syndrome associated with native valve or prosthesis dysfunction and more recently (since 1999) for any valve-replacement procedure. Consequently, the disease was diagnosed and treated in 6 patients between 1987 and 1993, 7 patients between 1994 and 1998, and 7 patients in the last 3 years. Macroscopic surgical evaluation was nonspecific and favored endocarditis in only 50% of cases, retrieving little vegetation and rare abscesses. The most common surgical observation was paraprosthetic leak with limited inflammation of the leaflets or the anulus or the bioprosthetic cusps. Moreover, Q fever was often assessed through systematic search on valvular material, thus emphasizing the role of the surgeon requesting systematic valvular sample analysis, particularly with patients submitted to repeated procedures for paravalvular leakage. We also observed that valve culture results were positive, even when medication had started before the operation. This underlines the particular resistance of the bacterium because of intracellular development and the importance of the surgical eradication, followed by long-term medical treatment under serologic guidance. Indeed, a difficult issue arises when active Q fever is demonstrated with normal prosthesis function, and medication alone can be proposed. Three of our medically treated patients were operated on during follow-up for regular structural deterioration, although earlier replacement should be indicated in any event as minimal paraprosthetic leak or accelerated dysfunction. Finally, our low mortality rate and the absence of relapses showed the benefit of our strategy.
Conclusion
Q fever might often go undetected in geographic low-risk zones, such as North America, although the lack of knowledge might be catastrophic everywhere. More aggressive search is recommended in a variety of situations, as shown in Table 1, including systematic analysis of surgical specimen obtained during valve procedures.
|
We thank J. P. Casalta, MD, and D. Raoult, MD, Director of the French National Center for Rickettsiae, for their long-lasting and fruitful cooperation, worldwide expertise, and friendship in Hospital La Timone, Marseille, France.
References
This article has been cited by other articles:
![]() |
S. Pagni, A. Dempsey, and E. H. Austin III Tricuspid and Aortic Valve and Ventricular Septal Defect Endocarditis: An Unusual Presentation of Acute Q Fever Ann. Thorac. Surg., December 1, 2009; 88(6): 2027 - 2029. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I Hasegawa, S. Kyo, H. Asano, and K. Imanaka Surgery for Active, Culture Negative Endocarditis Asian Cardiovasc Thorac Ann, December 1, 2004; 12(4): 316 - 319. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |